However, further sub-group analyses among the 55% of patients with data on Rhesus status (no information on CRT uptake), followed for a period of 4 years, showed improved survival in Rh-positive individuals with ischaemic cardiomyopathy. This evidence concerns the gene RHCE and cardiomyopathy.